{
  "docId": "019dd923-622c-750b-8b9a-e29456cbe117",
  "docSlug": "6acbd8e96867",
  "documentTitle": "Innovative Industrial Properties, Inc. (IIPR)",
  "authorId": "62_Grizzly_Research",
  "authorName": "Grizzly Reports",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2020-04-09 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 17,
  "pageCount": 36,
  "prevPage": 16,
  "nextPage": 18,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "balanced",
  "nDataPoints": 1,
  "notes": "Includes a screenshot of a growth facility at 1500 Esperanza Street, contradicting the claim that it is a retail dispensary.",
  "elementsJson": [
    "paragraph",
    "screenshot"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-e29456cbe117/17",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-e29456cbe117",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-e29456cbe117.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-e29456cbe117#slide-17",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "The one property PharmaCann sold to IIPR seems to us very problematic from a regulatory perspective.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-70f8-7007-94e1-b7e0be33645c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.51,
        "w": 0.78,
        "x": 0.11,
        "y": 0.46
      },
      "kind": "image",
      "text": "Screenshot of growth facility at 1500 Esperanza Street",
      "attrs": null,
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "592b746d-acb1-453c-b3dd-ccf2bd797159",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.78,
        "x": 0.11,
        "y": 0.35
      },
      "kind": "paragraph",
      "text": "The one property PharmaCann sold to IIPR seems to us very problematic from a regulatory perspective. According to its PR statement, DionyMed received a provisional retail license... However we found photos showing that this property is clearly used as a growth facility.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "53c2aaf1-ab85-42b1-9ff6-fbea01bba8e4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.78,
        "x": 0.11,
        "y": 0.09
      },
      "kind": "paragraph",
      "text": "Then in October, GLAS USA LLC and GLAS America LLC, as administrative agent and collateral agent under DionyMed Brands Inc.'s credit agreement dated January 2019, provided the company with notice of default under the credit agreement and demand for immediate payment of the amount of $24,810,682.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cabf48ab-bfc7-4666-840a-ec9333352619",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.78,
        "x": 0.11,
        "y": 0.23
      },
      "kind": "paragraph",
      "text": "Only a few days prior to receiving the notice, Edward Fields, DionyMed Brands Inc.'s chief executive officer, and Mark Zinselmeier, the company's interim chief operating officer, both resigned effective immediately.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ea476796-98b9-4bfa-81a0-665e3e38bdb7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "5b53c611-eda9-4f22-bfbb-c252ceccca5c",
      "evidence": "Contradicting public PR statements with visual evidence of facility usage",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 18,
      "from": 10,
      "beatId": "364af6ab-9a95-435c-b829-610042107d6d",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Expose Contradiction",
      "beatSlug": null,
      "evidence": "The report highlights contradictions in IIPR's business dealings, such as suspicious transactions and financial troubles of its tenants.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 18,
      "from": 9,
      "name": "Zoom In",
      "slug": "06-zoom-in",
      "bestFor": "Technical deep-dives, case studies, detailed analysis",
      "matchId": "6427974c-8712-4c50-958a-10078d43f3b9",
      "evidence": "The report zooms in on specific tenants, such as PharmaCann and Vireo, to highlight their financial troubles.",
      "position": 0,
      "objective": "What are the financial troubles of IIPR's tenants?",
      "structure": "The Big Picture -> Key Area of Focus -> Specific Detail -> Implication",
      "confidence": 0.7,
      "description": "Start broad, then progressively focus on specific details that prove your point"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}